Pardes Biosciences was a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. Founded in 2020 and based in Carlsbad, California, it used structure-based drug design and a tunable, reversible covalent chemistry platform. - View it on GitHub